- CureBay raised $21M Series B led by Bertelsmann India Investments to expand its rural healthcare network.
- These funds will strengthen CureBay’s tech stack and support entry into new states, leveraging AI for predictive care.
- The Odisha-based startup operates 150+ e-clinics and serves over 550,000 patients in underserved areas.
CureBay, a tech-driven hybrid healthcare platform, has secured $21 million in a Series B round led by Bertelsmann India Investments, with participation from Elevar Equity and British International Investment.
The startup that is headquartered in Odisha will use the new capital to enhance its proprietary technology stack and expand operations into new states, including Jharkhand, Bihar, Uttar Pradesh, and Madhya Pradesh.
CureBay was founded in 2021 to deliver last-mile primary healthcare through a network of over 150 e-clinics in small towns and villages across Odisha and Chhattisgarh.
Its services include doctor consultations, diagnostics, pharmacy access, and tertiary care, all integrated through its tech-enabled platform.
The company uses AI and data analytics to improve predictive care and operational efficiency and plans to invest further in platform upgrades, proprietary algorithms, and rural-first workflow automation tools.
Currently, CureBay’s preventive health program boasts 90,000 active members with a renewal rate exceeding 60%. The company claims to have served over 550,000 unique patients and aims to bring dignified, affordable healthcare to underserved communities.
According to regulatory filings, Bertelsmann is investing $11 million, British International Investment $4 million, and Elevar Equity $3.6 million in this round.
With this funding, CureBay’s post-money valuation is estimated at $75 million. The company reported a 16x jump in operating income for FY24 but also saw losses expand, reflecting the scale of its growth push.
Edited by Annette George
